-

$undefined

N/A

(N/A)

Cadrenal Therapeutics :CVKD

Location: | Industry: | Sector:

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

31.09M

Cash

4.364M

Avg Qtr Burn

-1.565M

Short % of Float

2.41%

Insider Ownership

32.37%

Institutional Own.

5.96%

Qtr Updated

09/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Tecarfarin Details End-Stage Renal Disease , Systemic thromboembolism, Atrial fibrillation	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tecarfarin Details Left Ventricular Assist Devices Patients	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.